Page 5 - 《中国药房》2022年1期

CHINA PHARMACY

Volume 33，Number 1，January 15，2022

Semimonthly
Table of Contents

Application of health technology assessment in 4 European countries and its enlightenment to China ……………
…………………………………………………………………………… YE Dongwei，WANG Li，LIU Shuwen（ 1 ）
Research on the technological innovation efficiency of Chinese listed biopharmaceutical enterprises based on the

two-stage DEA model ………………………………………………………… HAO Benchao，RUAN Xianjing（ 7 ）
Study on protective effects of methyl ferulate on mitochondria of H9c2 cardiomyocytes injured by hypoxia ……
……………………………………………………………………………………………… YANG Zan，ZHOU Yi（13）
Improvement effects of tilianin on atherosclerosis model mice and its mechanism study …………………………
………………………………………………………………………………………… CAO Wenjiang，XIN Pan，
ZHAO Yunli，YUAN Yong，GUO Xinhong，MA Xiaoli，HUANG Chuansheng，WEN Zhiping，WANG Xinchun（19）
Study on the improvement of quality standard for Tibetan medicine Qinjiaohua ……………………………………
…………………………………………………………… ZHONG Lu，LUO Shiying，ZHANG Jing，ZHANG Yi（26）
Study on spectrum-toxicity relationship of in vitro hepatotoxicity of aqueous extract from Euodia rutaecarpa …
LIU Shuling，WANG Jian，LIU Wen，HUANG Fengyu，JIANG Dongming，LIN Xiaotong，MENG Yiqin，LI Yaohua（32）
Study on absorbed components of Xiebai powder in rat blood ………………………………………………………
XU Dongchuan，LIU Jin，LI Xiaojing，YANG Qing，YANG Zongtong，ZHANG Huimin，SU Benzheng，SUI Zaiyun（38）
Study on effects and mechanism of Tibetan medicine Shanhu qishiwei pill in lowering blood lipid of hyperlipidemia

model rats ……………………………… CHUN Hua，WEI Dandan，ZHU Xinghao，WU Zongyao，Dawazhaba（46）
Study on the grade standard and quality evaluation of Panax quinquefolium ………………………………………
……………………………………………………… ZHANG Yang，CAI Guangzhi，LIU Xiaokang，GONG Jiyu（51）
Study on preparation，safety and anti-tumor activity of apigenin silk fibroin nanoparticles ………………………
………………………………… JI Peng，ZHANG Jinxiang，WANG Xianglong，GE Jianwen，HUANG Haiqin（ 58 ）
Study on the mitigation effects and mechanism of Astragalus membranaceus polysaccharides on monocrotaline-
induced pulmonary hypertension in rats ………………………………………… ZHANG Yukun，HE Dongping（64）
Study on the quality standard of Kuipingning gastric floating tablets ……………… WANG Baocai，LI Guoduo（ 69 ）
Pharmacoeconomic evaluation of empagliflozin in the treatment of heart failure with reduced ejection fraction …
…………………… WAN Yiming，SANG Haiqiang，DONG Jianzeng，JIA Yuchen，MA Huihui，JIANG Yaohui（74）
Literature analysis of leflunomide-induced interstitial pneumonia ……………………………………………………
………………………… ZENG Jiang，WANG Chunjiang，WU Hongwen，YANG Zhijie，LAN Tian，YE Chao（ 79 ）
Effects of Xuesaitong soft capsule on complement-inflammation receptor system in patients with type 2 diabetic
nephropathy ………… SHANG Haitao，ZHU Qing，PANG Xinxin，HAN Jiarui，ZHANG Shiwen，LI Mengyu（84）
Deferasirox for the treatment of iron overload in thalassemia：a rapid health technology assessment …… WANG
Junping，ZHANG Mei，WANG Guoyu，WU Zhengyu，ZHOU Peng，ZHANG Jiajia，NING Lijuan，GAO Shan（ 90 ）
Umeclidinium bromide and vilanterol trifenatate in the treatment of COPD：an overview of systematic review

and meta-analysis ………………………………………… LAN Ying，XU Min，LU Yiling，MA Qing，HE Qin（ 96 ）
Utilization analysis of monoclonal antibodies in China under the background of tiered healthcare delivery system
……………………………………………………………………… LI Yue，XU Xingying，WEI Li，LAI Yunfeng（104）
Promotion effects of trans-regional review system on rational drug use in second-grade general hospital ………
………………………… LIU Jing，CAI Ruijun，LI Juan，ZENG Xiuqin，XIE Xihui，WANG Dan，RU Aizhong（111）